In a report released yesterday, Whitney Ijem from Canaccord Genuity reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report), with a ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

Deal with Cantor Fitzgerald comes almost two years after Canaccord warned of a potentially ‘significant penalty’ related to ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of Talkspace (NasdaqCM:TALK) with a Buy recommendation. Analyst Price Forecast Suggests 82.80% Upside As of April 2, 2025, ...

LifeSpeak (TSE:LSPK – Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

Canaccord Genuity analyst Katie Lachapelle maintained a Buy rating on Sigma Lithium (SGML – Research Report) today and set a price target of ...

Canaccord Genuity Group restated their speculative buy rating on shares of Spirent Communications (LON:SPT – Free Report) in ...

Sale of U.S. market making business reinforces alignment of Canaccord Genuity's U.S. business with its global capital markets platform TORONTO, April 1, 2025 /CNW/ - Canaccord Genuity Group Inc ...

In the Men’s Premiership, Canaccord Genuity Vikings A kept their title hopes theoretically alive by recording a big 6-0 win ...

MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies ...